Growth Metrics

Ekso Bionics Holdings (EKSO) Total Current Liabilities (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Total Current Liabilities for 13 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 14.58% to $8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.6 million, a 14.58% increase, with the full-year FY2025 number at $8.6 million, up 14.58% from a year prior.
  • Total Current Liabilities was $8.6 million for Q4 2025 at Ekso Bionics Holdings, down from $8.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $10.1 million in Q2 2023 to a low of $4.7 million in Q3 2021.
  • A 5-year average of $7.4 million and a median of $7.6 million in 2024 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: soared 110.19% in 2023, then dropped 23.94% in 2024.
  • Ekso Bionics Holdings' Total Current Liabilities stood at $6.9 million in 2021, then skyrocketed by 34.22% to $9.2 million in 2022, then decreased by 11.78% to $8.1 million in 2023, then dropped by 7.15% to $7.5 million in 2024, then rose by 14.58% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Total Current Liabilities are $8.6 million (Q4 2025), $8.9 million (Q3 2025), and $6.7 million (Q2 2025).